FIRST EXTENSION - GRANTED
granted
on 04 Oct 2024
Last Applicant/ Owned by
7-11 BOULEVARD HAUSSMANN
PARIS
FR
75009
Serial Number
97400995 filed on 09th May 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ABIVAX
Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, musculoskeletal, viral, and fungal disease; vaccines for human and veterinary use; adjuvants for use with vaccines
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, musculoskeletal, viral, and fungal disease; vaccines for human and veterinary use; adjuvants for use with vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97400995
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Oct 2024 | SOU EXTENSION 1 GRANTED |
| 04th Oct 2024 | SOU EXTENSION 1 FILED |
| 04th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 09th Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 27th Mar 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 28th Feb 2024 | NEW NOA TO ISSUE |
| 28th Feb 2024 | NOTICE OF ALLOWANCE CANCELLED |
| 23rd Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Feb 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |